A federal judge partly sided with HHS over its decision to not approve proposals from Bristol Myers Squibb Co., Novartis AG, ...

Bristol Myers Squibb is calling on the world to chip in more for drug costs to support U.S. research and development. CEO ...

Residents living around a popular Bristol green space have formed a community group calling for more action against what they claim is growing dangerous and anti-social behaviour by van dwellers.

Bristol-Myers Squibb Company (NYSE:BMY) Q1 2025 Earnings Call Transcript April 24, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is $1.8, expectations were $1.49.

Bristol-Myers Squibb Company reported stronger-than-expected financial results for the first quarter of 2025, with earnings per share (EPS) of $1.80, surpassing analysts’ forecasts of $1.52. The ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the ...

The CHMP of the EMA recommended approval of a new Opdivo formulation associated with a new route of administration (subcutaneous use), a new pharmaceutical form (solution for injection ...

Bristol Myers Squibb Co. raised its sales and profit forecasts for the year on better-than-expected sales of older drugs and a favorable impact from the weaker dollar. The first quarter saw strong ...

Bristol-Myers Squibb Company reported stronger-than-expected financial results for the first quarter of 2025, with earnings per share (EPS) of $1.80, surpassing analysts’ forecasts of $1.52.

Bristol Myers Squibb on Thursday beat first-quarter estimates ... Pfizer scraps daily weight loss pill after liver injury in one patient Digital health startup Transcarent takes Accolade private ...

Hamburg, Germany, 24 April 2025: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced further significant progress of the Company’s strategic ...